Spago Nanomedical: Rights issue announced - Redeye

Redeye comments on Spago announcing a rights issue of up to SEK 61.8m in gross proceeds. The capital raise aligned with our expectations given the company’s guided financing runway, though the discount to the share’s latest trading price turned out somewhat higher than we had anticipated. Our valuation is under review until Spago announces the final outcome of the rights issue.

Länk till analysen i sin helhet: https://www.redeye.se/research/844227/spago-nanomedical-rights-issue-announced?utm_source=finwire&utm_medium=RSS